Trakcel fuels growth and increased market access through strategic investment round

Cardiff, wales--(business wire)--trakcel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed its latest funding round led by amerisourcebergen and labcorp (nyse: lh). these strategic investments enable further transformation of trakcel's cellular therapy orchestration solution, growth of its existing partner ecosystem, and continued global expansion. the company will use both the investment and the combined ex
LH Ratings Summary
LH Quant Ranking